Clinical Trials Logo
  1. Home
  2. Treatment Outcome
  3. NCT01364649

Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual Dysfunction

Treatment Outcome Clinical Trial

Official title:
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction

Clinical Trial Summary

The purpose of this study is to evaluate the effects of Vortioxetine (Lu AA21004), once daily (QD), compared with escitalopram on sexual functioning.

Clinical Trial Description

The drug being tested in this study is called Lu AA21004. Lu AA21004 is being tested to treat people who have major depressive disorder (MDD). This study will look at sexual function in people who take Lu AA21004.

The study will enroll approximately 440 patients. Participants will be randomly assigned (by chance, like flipping a coin) to one of the two treatment groups—which will remain undisclosed to the patient and study doctor during the study (unless there is an urgent medical need):

- Lu AA21004 10 to 20 mg

- Escitalopram 10 to 20 mg - This is a comparator drug that is also used to treat MDD.

All participants will be asked to take one tablet at the same time each day throughout the study. All participants will be asked to answer questionnaires at each study visit.

This multi-centre trial will be conducted in the United States and Canada. The overall time to participate in this study is 14 weeks. Participants will make 7 visits to the clinic, and will be contacted by telephone 21 days after last dose of study drug for a follow-up assessment. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01364649
Study type Interventional
Source Takeda
Contact
Status Completed
Phase Phase 3
Start date June 2011
Completion date December 2013
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT02993029 - 99Tc-MDP Treatment for Knee Osteoarthritis N/A
Enrolling by invitation NCT05411393 - Synergizing Home Health Rehabilitation Therapy N/A
Recruiting NCT05621356 - Monitoring Allergen Immunotherapy in Allergic Rhinitis
Not yet recruiting NCT05593380 - The Effect of BIA Monitoring of Brain Edema on the Neurological Prognosis of Supratentorial Massive ICH N/A
Recruiting NCT05964725 - The Study on Effect and Neural Network Mechanism of Transcranial Direct Current Stimulation for Sudden Deafness With Tinnitus N/A
Not yet recruiting NCT05417711 - Efficacy of Transcutaneous Vagus Nerve Stimulation Paired With Tailor-Made Notched Music Therapy Versus Tailor-made Notched Music Training for Chronic Subjective Tinnitus N/A
Recruiting NCT04013646 - Combination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients Phase 1/Phase 2
Not yet recruiting NCT03477240 - Feasibility Study Of A Telephonic Questionnaire For Follow-Up Of Locally Advanced Cervical Cancer Patients
Recruiting NCT06035783 - Calcium Reduction by Orbital Atherectomy in Western Europe
Recruiting NCT05413707 - Weber B Ankle Fractures With Associated Posterior Malleolus Fracture N/A
Completed NCT04682951 - Good Prognosis Factors After Decompressive Craniectomy : a Ten-year Retrospective Study
Recruiting NCT05616559 - Precision Medicine in the Depression Treatment
Recruiting NCT06441110 - Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer Phase 3
Recruiting NCT03223142 - Standardization of Multi-modal Tumor Ablation Therapy System N/A
Completed NCT05594160 - Agentic Self-view as Common Factor in Psychotherapy - Self-efficacy in the Treatment of Inpatients Over the Course of Time
Recruiting NCT05851989 - Study on Prognosis of Acutely Ruptured Intracranial Aneurysms
Not yet recruiting NCT05885919 - Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke Phase 3
Enrolling by invitation NCT06367829 - Lubinus SPII Hip Stem Target Trial Emulation (LARGE)
Active, not recruiting NCT01235104 - Impact of Total Nephrectomy on Patients With Kidney Stone N/A
Completed NCT01183936 - Trial of Surgical Excision Margins in Thick Primary Melanoma N/A